About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Phoenix | 242 Studies

Clinical Trials Alzheimer's DiseasePhoenix

Alzheimer's Disease Clinical Trials in Phoenix

Find 242 clinical trials for alzheimer's disease near Phoenix, Arizona. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 242 trials

TerminatedA 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseTo evaluate the safety and tolerability of ELND005 treatment with up to 36 weeks exposure, in Moderate to Severe AD patients with agitation and aggression.NCT01766336·Birmingham, Alabama and 45 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedAlzheimer's Disease Neuroimaging Initiative Grand OpportunityThe purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1), to examine how brain imaging technology…NCT01078636·Birmingham, Alabama and 54 others

TerminatedA Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)A study to evaluate the efficacy and safety of gantenerumab in amyloid-positive, cognitively unimpaired participants at risk for or at the earliest stages of AD.NCT05256134·Phoenix, Arizona and 62 others

CompletedA Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's DiseaseThis study seeks to evaluate the efficacy and safety of ABBV-8E12 in participants with early Alzheimer's disease (AD).NCT02880956·Phoenix, Arizona and 67 others

CompletedGAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's DiseaseThis is a randomized, double-blind, placebo-controlled study that assessed the efficacy, safety, and tolerability of 2 dose levels of COR388 in subjects with a clinical diagnosis…NCT03823404·Phoenix, Arizona and 92 others

CompletedStudy Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)The purpose of this study is determine the safety, tolerability, and efficacy of 3 doses of lecozotan SR in patients with mild to moderate Alzheimer's Disease over 12 weeks.NCT00151398·Phoenix, Arizona and 55 others

CompletedEfficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)The primary objective is to evaluate the efficacy of T-817MA as measured by ADAS-cog and ADCS-CGIC.NCT02079909·Phoenix, Arizona and 49 others

CompletedSafety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to determine the safety and efficacy of TRx0237 in the treatment of subjects with mild to moderate Alzheimer's Disease.NCT01689246·Phoenix, Arizona and 120 others

TerminatedA Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early ADThis is a Phase 2A multi-center, randomized, double blind, placebo-controlled, parallel group study of varoglutamstat, with a stage gate to Phase 2B.NCT03919162·Phoenix, Arizona and 21 others

CompletedAn Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD SubjectsThis study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype.NCT04770220·Phoenix, Arizona and 94 others

CompletedRosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseRosiglitazone (RSG) has been tested and is approved as a treatment for type II diabetes mellitus, a disease that occurs when the body ineffectively uses glucose.NCT00428090·Phoenix, Arizona and 137 others

CompletedThe Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT TrialThis multi-site clinical trial occurs at the University of Minnesota and University of Rochester.NCT03313895·Phoenix, Arizona and 3 others

CompletedA Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.NCT04777396·Phoenix, Arizona and 446 others

CompletedMetabolic Cerebral Imaging in Incipient Dementia (MCI-ID)A brain PET scan is recognized as "reasonable and necessary" for some patients with "a recently established diagnosis of dementia" (Centers for Medicare and Medicaid Services…NCT00329706·Phoenix, Arizona and 8 others

TerminatedA Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of five fixed dosage levels of FK962 or placebo for 24 weeks in subjects with mild to moderate Alzheimer's disease.NCT00087724·Phoenix, Arizona and 83 others

CompletedEfficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)Alzheimer's disease is the most common form of dementia and is the fourth leading cause of death among people 65 years of age and older.NCT01466088·Phoenix, Arizona and 32 others

TerminatedA Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaThe main purpose of this study is to evaluate the efficacy of the study drug known as lanabecestat in participants with mild Alzheimer's disease (AD) dementia.NCT02783573·Phoenix, Arizona and 261 others

CompletedA Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On MemantineThis is a randomized double-blind Placebo-controlled, Phase 2 study comparing bryostatin to placebo for the treatment of moderately severe to severe Alzheimer's disease in…NCT03560245·Fresno, California and 27 others

Active not recruitingA Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADThe goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85.NCT06709014·Chandler, Arizona and 77 others

CompletedA Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's AgitationTo compare the efficacy of 2 fixed doses of brexpiprazole with placebo in participants with agitation associated with dementia of the Alzheimer's type.NCT01862640·Tuscaloosa, Alabama and 84 others

PreviousPage 3 of 13Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia